Envoy Medical (COCH) Profit After Tax (2021 - 2026)

Envoy Medical (COCH) has 6 years of Profit After Tax data on file, last reported at -$5.7 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax rose 8.58% year-over-year to -$5.7 million; the trailing twelve-month figure through Mar 2026 stood at -$24.5 million (down 17.83% YoY), and the FY2025 full-year result was -$23.8 million, down 14.24% from the prior year.
• Profit After Tax grew to -$5.7 million in Q1 2026, from -$6.6 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $1.6 million in Q3 2023 to a low of -$13.3 million in Q2 2023.
• A 5-year average of -$5.7 million and a median of -$5.7 million in 2026 frame the typical range for Profit After Tax.
• Peak annual rise in Profit After Tax reached 216.47% in 2023, while the deepest fall reached 979.05% in 2023.
• Tracing COCH's Profit After Tax over 5 years: stood at -$11.5 million in 2022, then surged by 57.32% to -$4.9 million in 2023, then advanced by 5.72% to -$4.6 million in 2024, then sank by 42.68% to -$6.6 million in 2025, then gained by 13.48% to -$5.7 million in 2026.
• Business Quant data shows COCH's Profit After Tax at -$5.7 million in Q1 2026, -$6.6 million in Q4 2025, and -$6.5 million in Q3 2025.